Hong Kong Hosts First Overseas Edition of China’s Largest Chest Pain Congress

Hong Kong has reached a new milestone in its development as an international meetings hub, becoming the first city outside Chinese Mainland to host the China Chest Pain Centers Congress (CCPCC 2026), the country’s largest conference dedicated to chest pain centres. The achievement was supported by the Hong Kong Convention Ambassador (HKCA) programme, led by the Hong Kong Tourism Board (HKTB).

The event forms part of a strong start to 2026 for the city’s medical meetings sector, following the successful delivery of the 41st Asia Pacific Academy of Ophthalmology Congress in February and the 17th Asian Congress of Oral & Maxillofacial Surgery in March. Together, these gatherings highlight Hong Kong’s growing role as a platform for international medical exchange.

Ms Marilyn Tham, General Manager of Mega Events, MICE & Cruise at HKTB, said, “Hong Kong’s leading edge in medical sciences coupled with the city’s world-class venues and destination appeal have enabled notable success for internationally significant medical events. CCPCC 2026 is one of the large-scale medical conventions confirmed for 2026. Such robust lineup reflects event organisers’ confidence in Hong Kong as a premier hub for advancing global exchanges on medical sciences.”

In total, more than 10 medical conventions are scheduled to take place in Hong Kong this year, covering a wide range of disciplines including cytology, oncology and antimicrobial resistance. The breadth of the programme underlines the city’s increasing appeal as a convening point for global medical expertise.
 

Globalising Chest Pain Leadership from Hong Kong 

Held on 3–4 April 2026 at the Hong Kong Convention and Exhibition Centre, with a concurrent venue in Shenzhen, CCPCC 2026 brought together around 3,000 healthcare professionals, including physicians, nurses, researchers, policymakers and industry leaders from Hong Kong, Chinese Mainland and international markets. The programme addressed topics such as healthcare innovation, AI-assisted clinical decision-making, emergency response systems and international accreditation standards.

The congress was co-organised by leading institutions across Hong Kong and Chinese Mainland, reflecting strong cross-border collaboration in advancing cardiovascular care. Mr. Wenming Zeng (on the right), Secretary-General of OHCHRI, remarked, “The global influence of CCPCC has been growing over the years. Thanks to Hong Kong’s strategic location, leading medical standing and its unique role bridging Chinese Mainland and the world, this year’s congress has drawn even wider global participation, giving the event greater international significance. Hong Kong has helped showcase our event to the world, taking cardiovascular emergency intervention to a new height globally.”

A key outcome of the congress was the release of the “International Standards on Chest Pain Center Construction and Accreditation”, marking the first time such standards have been introduced on an international stage. The initiative reflects efforts to expand Mainland China’s leadership in cardiovascular emergency care while leveraging Hong Kong’s role as a global connector to support wider adoption and implementation.
 

Another Significant Win for HKCA Programme on its 5th Anniversary 

The event also highlights the impact of the HKCA programme, which connects more than 170 leaders and academics across 13 industries to promote Hong Kong as a global meetings destination. Prof Lu Shi-Juan (right side), a Hong Kong Convention Ambassador, played a key role in bringing the congress to the city.

Prof Lu noted, “As a Hong Kong International Convention Ambassador, I have worked closely with the HKTB to bring CCPCC to Hong Kong, which is a gateway to the global stage. Hosting the conference here showcases how Hong Kong can elevate Mainland conferences internationally, foster cross-border knowledge exchange and help shape the future development of the broader medical and professional community.”

Since its launch, the HKCA programme has contributed to securing 50 international conventions, attracting nearly 100,000 high-value overnight MICE visitors and reinforcing Hong Kong’s position as a leading global meeting place.
 

Strong Medical Events Lineup in 2026

Over 10 major medical congresses were confirmed in Hong Kong for 2026, covering diverse fields from oncology and cytology to antimicrobial resistance and longevity medicine.

Flagship regional and global events include:

• Asia-Pacific Academy of Ophthalmology Congress (11,000+ participants from 111 countries);
• Asian Congress of Oral & Maxillofacial Surgery
• World Cancer Congress (global forum on cancer control)

First-time events in Hong Kong highlight growing international appeal:

• Asian Federation of Cytology Societies Conference
• Other specialised scientific and medical gatherings

Key thematic areas represented:

• Oncology and cancer research
• Infectious diseases and antimicrobial resistance
• Biochemistry and molecular biology
• Longevity medicine and ageing
• Ophthalmology and specialised surgical fields

Strong Asia-Pacific and global participation, bringing together researchers, clinicians, policymakers and industry leaders.

Mix of established and emerging platforms, reinforcing Hong Kong’s role as a hub for both recurring flagship congresses and new international meetings.
 

Powered by Meeting Media Company, publisher of Headquarters Magazine (HQ) – a leading international publication based in Brussels, serving the global MICE industry and association community.